Introduction to Cancer Prostate

What is/are Cancer Prostate?

Cancer Prostate - Conclusion: TB of the prostate may present like cancer prostate with raised serum PSA and suspicious prostate on DRE; hence, a high index of suspicion with a wide range of investigations may be required to achieve a complete diagnosis of prostatic TB. ^[1] The current case control study was conducted to ascertain the risk of association of GSTP1polymorphism with risk of cancer prostate in an Eastern Indian population. ^[2] Objective: our study aimed to evaluate the sensitivity of multiparametric magnetic resonance (MR) imaging in detection of cancer prostate, using the Prostate Imaging Reporting and Data System (PIRADS) version 2. ^[3]

serum testosterone level

The present study is to find out the role of low serum testosterone level in predicting prostate cancer behaviour in comparison with normal serum testosterone level patients and to find out the relationship between low serum testosterone level and serum PSA levels in TRUS biopsy proven cancer prostate patients. ^[1]

cancer prostate cancer

This is clearly demonstrated in prostate cancer, which now accounts for 400,000 new cancer prostate cancer cases across Europe (1), 160,000 in the US (2) annually, and is now the second most frequent malignancy (after lung cancer) diagnosed globally—1,276,106 men (3). ^[1] To address this gap a preliminary study was conducted to determine the feasibility, safety and preliminary efficacy of a 12-week high-intensity combined aerobic and resistance exercise training program, compared to usual care, on early markers of CVD risk and sexual health (Chapter 5) in those living with and beyond cancer prostate cancer (n = 15). ^[2] Clinical concepts for cabazitaxel in the management of metastatic castration-resistant prostate cancer Prostate cancer (PCa) is one of the most common health-related issues in the male individuals. ^[3]

cancer prostate patient

We aimed to evaluate the effect of metformin addition to androgen deprivation therapy (ADT) among cancer prostate patients with type 2 DM. ^[1] The present study is to find out the role of low serum testosterone level in predicting prostate cancer behaviour in comparison with normal serum testosterone level patients and to find out the relationship between low serum testosterone level and serum PSA levels in TRUS biopsy proven cancer prostate patients. ^[2] Conclusion This preliminary study showed a high prevalence of muscle disorders before initiation of ADT in a population of elderly cancer prostate patients with intermediate frailty status, and an increased risk of falls at the end of ADT. ^[3]

cancer prostate therapy

Finally, the MgO-PEG-2ME NPs decreased the viability of the prostate cancer cell line LNCap suggesting that this nanocomposite is suitable as a drug delivery system for anticancer prostate therapy. ^[1] Finally, the MgO-PEG-2ME NPs decreased the viability of the prostate cancer cell line LNCap suggesting that this nanocomposite is suitable as a drug delivery system for anticancer prostate therapy. ^[2]